RecruitingPhase 2Phase 3NCT04351347
The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
Clinical Study Evaluating the Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
Sponsor
Tanta University
Enrollment
300 participants
Start Date
Jun 16, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
Efficacy of Ivermectin in larger doses in COVID-19 treatment
Eligibility
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Ivermectin for people with covid. The study is currently recruiting participants at 1 location.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGIvermectin
ivermectin
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04351347
Related Trials
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
NCT0491026966 locations
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
NCT0345277468 locations
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
NCT072210976 locations
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
NCT067446603 locations
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
NCT043621501 location